4-Chloro-N-[6,8-dibromo-2-(2-thienyl)imidazo[1,2-a]pyridine-3-yl]benzamide
- $193 - $1143.02
- Product name: 4-Chloro-N-[6,8-dibromo-2-(2-thienyl)imidazo[1,2-a]pyridine-3-yl]benzamide
- CAS: 372497-52-4
- MF: C18H10Br2ClN3OS
- MW: 511.62
- EINECS:
- MDL Number:MFCD01943217
- Synonyms:4-Chloro-N-[6,8-dibromo-2-(2-thienyl)imidazo[1,2-a]pyridine-3-yl]benzamide;Benzamide, 4-chloro-N-[6,8-dibromo-2-(2-thienyl)imidazo[1,2-a]pyridin-3-yl]-;4-chloro-N-[6,8-dibromo-2-(thiophen-2-yl)imidazo[1,2-a]pyridin-3-yl]benzamide
4 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Sigma-Aldrich
- TRC
Package
- 5MG
- 25MG
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberAPI0008444
- Product descriptionDS1 95.00%
- Packaging5MG
- Price$728
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberAPI0008444
- Product descriptionDS1 95.00%
- Packaging25MG
- Price$1143.02
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberD0446
- Product descriptionDS1 ≥98% (HPLC)
- Packaging5mg
- Price$193
- Updated2022-05-15
- Buy
- ManufacturerTRC
- Product numberC982605
- Product descriptionDS1
- Packaging25mg
- Price$530
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | API0008444 | DS1 95.00% | 5MG | $728 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | API0008444 | DS1 95.00% | 25MG | $1143.02 | 2021-12-16 | Buy |
Sigma-Aldrich | D0446 | DS1 ≥98% (HPLC) | 5mg | $193 | 2022-05-15 | Buy |
TRC | C982605 | DS1 | 25mg | $530 | 2021-12-16 | Buy |
Properties
storage temp. :2-8°C
solubility :DMSO: >10mg/mL
form :powder
color :off-white to tan
solubility :DMSO: >10mg/mL
form :powder
color :off-white to tan
Safety Information
Symbol(GHS): | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||
Hazard statements: |
|
||||||||||||||
Precautionary statements: |
|